Pulmonary squamous cell carcinoma and sorafenib
KEY CLINICAL MESSAGEPulmonary squamous cell carcinomas are not often thought to sensitive to targeted agents, like their cousin the adenocarcinoma of the lung. With appropriate testing of molecular markers, squamous cell carcinomas, like adenocarcinomas of the lung, melanomas, and renal cell carcino...
Gespeichert in:
| Veröffentlicht in: | Clinical case reports 2014, Vol.2 (5), p.206-208 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Report |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | KEY CLINICAL MESSAGEPulmonary squamous cell carcinomas are not often thought to sensitive to targeted agents, like their cousin the adenocarcinoma of the lung. With appropriate testing of molecular markers, squamous cell carcinomas, like adenocarcinomas of the lung, melanomas, and renal cell carcinomas, may be found to be sensitive to newer, targeted agents. |
|---|---|
| ISSN: | 2050-0904 2050-0904 |
| DOI: | 10.1002/ccr3.95 |